Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank21
3Y CAGR-15.1%
5Y CAGR-22.7%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-15.1%/yr
vs -36.9%/yr prior
5Y CAGR
-22.7%/yr
Recent acceleration
Acceleration
+21.7pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20253.20-14.3%
20243.74+33.9%
20232.79-46.7%
20225.24-8.0%
20215.69-50.9%
202011.59+43.2%
20198.10-75.5%
201833.02+118.8%
201715.09-55.8%
201634.12-